Comments

X4 Pharmaceuticals

XFORNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.759000
0.011.47%
At Close: -
$0.740000
-0.02-2.50%
After Hours: Jul 19, 6:32 PM EDT
15 minutes delayed
X4 Pharmaceuticals (XFOR) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$1.00
Consensus Price Target1
$4.50

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

X4 Pharmaceuticals (NASDAQ:XFOR) Stock, Analyst Ratings, Price Targets, Forecasts

X4 Pharmaceuticals Inc has a consensus price target of $4.5 based on the ratings of 8 analysts. The high is $10 issued by Canaccord Genuity on April 5, 2022. The low is $1 issued by B. Riley Securities on December 12, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Cantor Fitzgerald, and HC Wainwright & Co. on June 28, 2024, May 31, 2024, and April 30, 2024, respectively. With an average price target of $5 between HC Wainwright & Co., Cantor Fitzgerald, and HC Wainwright & Co., there's an implied 575.68% upside for X4 Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
Apr
1
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Cantor Fitzgerald
B. Riley Securities
Stifel
B. Riley Securities

1calculated from analyst ratings

Analyst Ratings for X4 Pharmaceuticals

Buy NowGet Alert
06/28/2024Buy Now575.68%HC Wainwright & Co.
Swayampakula Ramakanth
$5 → $5ReiteratesBuy → BuyGet Alert
05/31/2024Buy Now575.68%Cantor Fitzgerald
Kristen Kluska
$5 → $5ReiteratesOverweight → OverweightGet Alert
04/30/2024Buy Now575.68%HC Wainwright & Co.
Swayampakula Ramakanth
$3 → $5MaintainsBuyGet Alert
03/22/2024Buy Now305.41%HC Wainwright & Co.
Swayampakula Ramakanth
 → $3ReiteratesBuy → BuyGet Alert
12/12/2023Buy Now35.14%B. Riley Securities
Kalpit Patel
$3 → $1DowngradeBuy → NeutralGet Alert
08/11/2023Buy Now305.41%HC Wainwright & Co.
Swayampakula Ramakanth
 → $3ReiteratesBuy → BuyGet Alert
05/17/2023Buy Now575.68%Stifel
Stephen Willey
$4 → $5MaintainsBuyGet Alert
05/05/2023Buy Now305.41%HC Wainwright & Co.
Swayampakula Ramakanth
 → $3Reiterates → BuyGet Alert
04/10/2023Buy Now305.41%B. Riley Securities
Mayank Mamtani
$7 → $3MaintainsBuyGet Alert
03/24/2023Buy Now440.54%Oppenheimer
Leland Gershell
$5 → $4MaintainsOutperformGet Alert
03/22/2023Buy Now305.41%Cantor Fitzgerald
Kristen Kluska
 → $3MaintainsOverweightGet Alert
03/22/2023Buy Now305.41%HC Wainwright & Co.
Swayampakula Ramakanth
$5 → $3MaintainsBuyGet Alert
12/22/2022Buy Now305.41%Cantor Fitzgerald
Kristen Kluska
 → $3Initiates → OverweightGet Alert
12/12/2022Buy Now305.41%Piper Sandler
Edward Tenthoff
 → $3Initiates → OverweightGet Alert
11/30/2022Buy Now575.68%HC Wainwright & Co.
Swayampakula Ramakanth
$3.5 → $5MaintainsBuyGet Alert
05/19/2022Buy Now845.95%B. Riley Securities
Mayank Mamtani
$10 → $7MaintainsBuyGet Alert
05/13/2022Buy Now1048.65%HC Wainwright & Co.
Swayampakula Ramakanth
$11 → $8.5MaintainsBuyGet Alert
04/05/2022Buy Now1251.35%Canaccord Genuity
Arlinda Lee
$20 → $10MaintainsBuyGet Alert
12/14/2021Buy Now1386.49%HC Wainwright & Co.
Swayampakula Ramakanth
—MaintainsBuyGet Alert

FAQ

Q

What is the target price for X4 Pharmaceuticals (XFOR) stock?

A

The latest price target for X4 Pharmaceuticals (NASDAQ:XFOR) was reported by HC Wainwright & Co. on June 28, 2024. The analyst firm set a price target for $5.00 expecting XFOR to rise to within 12 months (a possible 575.68% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for X4 Pharmaceuticals (XFOR)?

A

The latest analyst rating for X4 Pharmaceuticals (NASDAQ:XFOR) was provided by HC Wainwright & Co., and X4 Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for X4 Pharmaceuticals (XFOR)?

A

There is no last upgrade for X4 Pharmaceuticals

Q

When was the last downgrade for X4 Pharmaceuticals (XFOR)?

A

The last downgrade for X4 Pharmaceuticals Inc happened on December 12, 2023 when B. Riley Securities changed their price target from $3 to $1 for X4 Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for X4 Pharmaceuticals (XFOR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of X4 Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for X4 Pharmaceuticals was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.

Q

Is the Analyst Rating X4 Pharmaceuticals (XFOR) correct?

A

While ratings are subjective and will change, the latest X4 Pharmaceuticals (XFOR) rating was a reiterated with a price target of $5.00 to $5.00. The current price X4 Pharmaceuticals (XFOR) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch